Emmaculate Nzove
Dados Biográficos
| ID | 9063350 |
|---|---|
| NOME | Emmaculate Nzove |
| PRENOMES | Emmaculate |
| SOBRENOME | Nzove |
| ASSINATURA | NZOVE E |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2025 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Evaluating the safety of prenatal HIV PrEP use
Existing data support the safety of daily oral tenofovir disoproxil fumarate (TDF)-based HIV pre-exposure prophylaxis (PrEP) use in pregnancy, yet ongoing monitoring is needed. We analyzed data from three recently completed HIV PrEP safety and implementation studies (PrIMA, PrIMA-X, and mWACh-PrEP) that enrolled women who were offered and/or initiated TDF-based HIV PrEP at routine health clinics in Western Kenya to summarize perinatal outcomes fo…
Cofactors of earlier uptake of modern postpartum family planning methods in Kenya
There are limited data on uptake of postpartum family planning (FP), particularly in high HIV prevalence settings. We assessed the timing of modern postpartum FP initiation and the cofactors of earlier uptake using longitudinal data from a clinical trial conducted in Kenya to assess two models of PrEP delivery among pregnant and postpartum women (NCT#03070600). Time to uptake of modern postpartum FP was estimated using survival analysis methods, …
Sem obras proeminentes nesta página.
Cofactors of earlier uptake of modern postpartum family planning methods in Kenya
There are limited data on uptake of postpartum family planning (FP), particularly in high HIV prevalence settings. We assessed the timing of modern postpartum FP initiation and the cofactors of earlier uptake using longitudinal data from a clinical trial conducted in Kenya to assess two models of PrEP delivery among pregnant and postpartum women (NCT#03070600). Time to uptake of modern postpartum FP was estimated using survival analysis methods, …
Evaluating the safety of prenatal HIV PrEP use
Existing data support the safety of daily oral tenofovir disoproxil fumarate (TDF)-based HIV pre-exposure prophylaxis (PrEP) use in pregnancy, yet ongoing monitoring is needed. We analyzed data from three recently completed HIV PrEP safety and implementation studies (PrIMA, PrIMA-X, and mWACh-PrEP) that enrolled women who were offered and/or initiated TDF-based HIV PrEP at routine health clinics in Western Kenya to summarize perinatal outcomes fo…
HIV/AIDS Research and Interventions (2 obras) · Pregnancy (2 obras) · Adolescent Sexual and Reproductive Health (1 obras) · Cohort (1 obras) · Cohort study (1 obras) · Environmental health (1 obras) · Family planning (1 obras) · Gestation (1 obras) · Gestational age (1 obras) · Global Maternal and Child Health (1 obras)